Association between post procedural parenteral anticoagulation therapy and clinical outcomes in ST-elevation myocardial infarction patients with high thrombotic risk
Background Current guidelines advise against routine use of parenteral anticoagulation therapy (PACT) for ST-segment elevated myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI). However, the effectiveness of PACT in such patients with high thrombotic risk remains uncertain. To determi...